AE Wealth Management LLC Has 1.97 Million Position in Edwards Lifesciences Co. - MarketBeat
| EWL Stock | EUR 71.55 1.47 2.10% |
Roughly 55% of Edwards Lifesciences' stockholders are presently thinking to get in. The analysis of current outlook of investing in Edwards Lifesciences suggests that some traders are interested regarding Edwards Lifesciences' prospects. The current market sentiment, together with Edwards Lifesciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Edwards Lifesciences stock news signals to limit their universe of possible portfolio assets.
Edwards Lifesciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Edwards daily returns and investor perception about the current price of Edwards Lifesciences as well as its diversification or hedging effects on your existing portfolios.
Edwards |
AE Wealth Management LLC Has 1.97 Million Position in Edwards Lifesciences Co. MarketBeat
Read at news.google.com
 |
Edwards Lifesciences Fundamental Analysis
We analyze Edwards Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edwards Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edwards Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
Edwards Lifesciences is one of the top stocks in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Edwards Lifesciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Edwards Lifesciences stock to make a market-neutral strategy. Peer analysis of Edwards Lifesciences could also be used in its relative valuation, which is a method of valuing Edwards Lifesciences by comparing valuation metrics with similar companies.
Peers
Edwards Lifesciences Related Equities
| EWL | Edwards Lifesciences | 2.10 | ||||
| 2M6 | Medtronic PLC | 1.43 | ||||
| SYK | Stryker | 1.25 | ||||
| SHL | Siemens Healthineers | 0.72 | ||||
| ABL | Abbott Laboratories | 0.73 | ||||
| BSX | Boston Scientific | 1.16 | ||||
| AFW | Align Technology | 1.61 |
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |